Академический Документы
Профессиональный Документы
Культура Документы
Contents
Introduction Classification Inflammatory Enlargement Drug induced enlargement. Combined enlargement Enlargements associated with systemic diseases. Conditioned enlargement Systemic diseases causing gingival enlargement Neoplastic enlargement: Malignant Benign. False enlargements Treatment. Conclusion.
2
Introduction
Increase in the size of the gingiva,is called gingival enlargement.
Classification
on the basis of etiologic factor and pathologic changes
Inflammatory enlargements a)Acute b)Chronic Drug induced enlargement Enlargements associated with systemic diseases and condition A. Conditioned enlargement 1.Pregnancy 2.Puberty 3. Vitamin C deficiency
4.Plasma cell gingivitis 5.Nonspecific conditioned enlargement( Granuloma pyogenicum) B. Systemic diseases causing gingival enlargement. Leukemia Granulomatous diseases ( Wegeners granulomatosis, sarcoidosis ) Neoplastic enlargement (gingival tumours) A.Benign tumours B. Malignant tumours False enlargement.
5
On the basis of location and distribution Localised Generalised Marginal Papillary Diffuse Discrete
Inflammatory enlargement.
ACUTE
CHRONIC
Clinical features
Originate as slight balloning of interdental papilla. Life preserver shape bulge around involved tooth Discrete sessile or pedunclated mass interproximal or on the marginal or attached gingival.
Histopathology Exudative and proliferative features of chronic inflammation. Deep red lesions or bluish red lesions
Soft & friable Smooth and shiny surface Bleed easily Preponderance of inflammtory cells and fluid
11
In mouth breathers, red and erythematous diffuse surface shininess of exposed area.
Most common site maxillary anteriors. attributed to irritation from surface dehydration. Klingsberg etal (1961) in his study proved that changes in the gingiva could not be produced by air drying the gingiva.
12
treatment
Scaling and root planing If necessary surgical removal:
Gingivectomy Flap operation
13
-Adjacent teeth are usually sensitive to percussion -If permitted to progress , generally ruptures spontaneously.
14
Etiology
bacteria carried deep into the tissues foreign substance such as a tooth brush bristle , a piece of apple core, or a lobster shell fragment is forcefully embedded in to the gingiva.
15
Histopathology Purulent focus in the connective tissue . diffuse infiltration of polymorphonuclear leukocytes, edematous tissue, vascular engorgement. Surface epithelium intra and extracellular edema, invasion by leukocytes and sometimes ulceration.
16
treatment
Drainage and irrigation of the abscess.
17
Periodontal abscess. -Localised purulent inflammation in the periodontal tissues. -Otherwise called lateral or parietal abscess. Periodontal pocket of 5-8mm Tender on percussion Pain Foul taste Mobility of involved teeth Tenderness over the corresponding gingiva
18
Pathogenesis
Extension of infection from periodontal pocket supporting periodontal tissues. Lateral extension of inflammation from inner surface of a periodontal pocket connective tissue . Formation in a pocket with tortuous course around the root. Incomplete removal of calculus. after trauma to the tooth or in endodontic therapy.
19
Histopathology
viable and nonviable PMNs enzymes. acute inflammatory reaction sorrounding the prulent area epithelium intracellular and extracellular edema and invasion of leukocytes. Localized acute abscess chronic abscess
20
De witt etal (1985) The invading organisms identified were gram negative cocci , diplococci, fusiforms, and spirochaetes. Newmann (1979) microorganisms that colonized the periodontal abscess were primarily gram negative anaerobic rods.
21
treatment
Drainage and irrigation Pocket elimination procedure
22
23
Clinical features.
-a painless beadlike enlargement of the interdental papilla massive fold covering a considerable portion of the crowns may interfere with occlusion. Lesions uncomplicated by inflammation mulberry shaped, firm, pale pink,resilient and minutely lobulated surface and with no tendency to bleed.
24
usually generalized ,more severe in the maxillary and mandibular anterior regions. areas where teeth are present and absent in edentulous spaces. It dissapears in areas from which teeth are extracted
Malpositioning
25
chronic and slowly increases in size . When surgically removed It recurs. Spontaneous disappearance few months after discontinuation of the drug. May occur in mouths with little or no plaque and May be absent in mouths with abundant deposits.
26
27
Anticonvulsants
The first drug- induced enlargements were those produced by phenytoin (Dilantin). Introduced by Meritt and Putnam in 1938 All forms of epilepsy except petitmal. Other hydantoins known to induce gingival enlargement are ethotoin (Peganone),Mephenytoin (Mesatoin)
Other anticovulsants that have the same side effect are the succinimides ( ethosuximide zerontin, methosuxinimide celontin,)and valproic acid (Depakene)
28
Seymour etal (1996) Gingival enlargement occurs in about 50% of the patients receiving the drug Different authors have reported incidences from 3% to 84.5%..
29
Pharmacokinetics
Phenytoin
Depresses the motor cortex of CNS Stabilises the neuronal discharge Limits progression of neuronal excitation. Block calcium influx across cell membranes.
30
Pathogenesis
Effect on human gingival fibroblasts Tissue culture experiments by Shafer (1960,1961) phenytoin stimulates proliferation of fibroblast like cells and decrease in degradation of collagen. two analogues of phenytoin(1allyl 5 phenylhydantoinate and 5-methyl-5 phenyl hydantoinate) have similar effect on fibroblast like cells.
31
Hassell and Hefti(1991) Phenotypically distinct and different subpopulations of fibroblasts. Phenotoin reacts with some but not all.
33
Increased glycosaminoglycans Dahloff et al (1984) Phenytoin induced enlargementIncreased GAG. Pagiarini et al (1995) Effect of phenytoin induced gingival enlargement on glycosaminoglycan synthesis in fibroblasts. Attached gingival fibroblasts-increased intracellular GAGs Free gingival fibroblasts-extracellular sulfated GAGs Kantor ML et al(1953) reported that fibroblast from a phenytoin induced gingival over growth show increased synthesis of sulfated glycosaminoglycans in vitro.
34
35
36
37
Seymour (1996) its occurrence are not necessarily related to the dosage after the threshold levels have been exceeded Shapiro (1957) systemic administration of phenytoin accelerates the healing of gingival wounds in nonepileptic humans. increase the tensile strengths of healing in abdominal wound in rats (Decosta1988)
38
Histopathology
Thick stratified squamous epithelium Elongated retepegs extend deep in to the connective tissue. Densely arranged collagen bundles Increase in the number of fibroblasts, New blood vessels. Abundance of amorphous ground substance
39
Combined enlargement
enlargement makes difficult plaque control secondary inflammatory reaction increase in the size red or bluish red discolouration obliterate the lobulated surface demarcations, increased tendency towards bleeding.
40
However oral hygiene by tooth brushing(Elzay RP1964) or the use of chlorhexidiene toothpaste(Russel 1978) reduces the inflammation but does not lessen or prevent the overgrowth. Dallas B M et al(1963),Dreyer et al (1978) hyperplasia of mucosa in edentulous mouths.
41
Hassell et al (1978) Non-inflamed gingival fibroblasts are less active or even quiescent and do not respond to circulating phenytoin, where as fibroblasts within the inflamed tissue are in an active state as a result of the inflammatory mediators and endogenous growth factors present. Hassell (1994) and Raeste (1978) genetic predisposition is a suspected factor in determining whether a person treated with phenytoin will develop gingival enlargement or not.
42
Immunosupressants
Isolated in Switzerland in 1970 Fungus-Tolypocladium inflatum Gams. Cyclic polypeptide Cyclosporine A (Sandimmune, Neoral) intravenously or by mouth , and dosages greater than 500 mg /day have been reported to induce gingival overgrowth. Immunosupressive action. B cells and to a greater extent T cells. Dosage-10-20mg/kg body weight.
43
Pharmacokinetics.
Specific and reversible inhibition of immunocompetent lymphocytes.(T helper cells) Cyclosporin A inhibits interleukin-2 synthesis. Inhibits the ability of cytotoxic T cells to respond to IL-2. Inhibits the activation of macrophages Prevents the production of IL-1 receptors on the T helper cells.
44
Seymour et al (1987)
Cyclosporine induced gingival enlargement is more vascularised than the phenytoin enlargement. 30% of patients receiving the drug . more frequent in children .
magnitude appears to be related more to plasma concentration than to the patients periodontal status.
45
Thomason et al (1993, 1996) Gingival enlargement is greater in patients who are medicated with both cyclosporine and calcium channel blocking agents.
The microscopic finding of many plasma cells plus the presence of an abundant amorphous extracellular substance has suggested that the enlargement is a hypersensitivity response to the cyclosporine.
46
Ayanoglou et al (1997 in experimental animals, oral administration of cyclosporine also induced abundant formation of new cementum. Other than gingival enlargement, cyclosporine also induces other major side effects such as nephrotoxicity, hypertension and hyperthricosis Another immunosuppressive drug called tacrolimus has been used effectively and is also nephrotoxic , but it results in much less severe hypertension, hyperthricosis and gingival overgrowth.
47
Clinical manifestations
More pronounced in the labial gingiva. Considerable bleeding on surgical removal. More restricted to keratinised gingiva. May extend coronally Absent in edentulous patients. Soft, red, bluish red, extremely fragile. Caused migration and malposition.
48
Pathogenesis
Cyclosporin A and its metabolite react with phenotypically distinct subpopulations of fibroblastsincrease in protein synthesis, rate of proliferation. Genetic predispositions.HLA -DR1 Iacopino et al(1997) PDGf B and messenger RNA is significantly increased .
49
Histopathology
Connective tissue with an irregular parakeratinised multilayered epithelium.
50
Calcium Channel Blockers Treatment of cardiovascular conditions inhibit calcium ion influx across the cell membrane. Direct dilation of the coronary arteries and arterioles , improving tension by dialating the peripheral vasculature. 15-83% of patients taking nifedipine.
51
classification
Benzothiazepine derivatives Diltiazem Phenylalkylamine derivatives Verapamil Substituted dihydropyridines Amlodipine,felodipine,isradipine,nicardipine,nifedipine, oxodipine,nimodipine,nisoldipine.
52
Clinical manifestations
Interdental papilla-nodular and lobulated appearance Limited to attached and marginal gingiva
53
Pathogenesis
Ability to affect the calcium metabolism. Effects the cell proliferation, DNA synthesis and collagen synthesis Factors affecting the enlargement- dosage, age, duration of medication , length of time taken, sequestration of the agent in the GCF. Reduction in the cytosolic calcium levels in gingival fibroblasts
54
Barclay (1992) gingival enlargement in 20% of the cases. Diltiazem , felodipine, nitrendipine and verapamil also induce gingival enlargement .
55
The dihydropyridine derivative isradipine can in some cases replace nifedipine and does not induce gingival overgrowth. Nifedipine is also used with cyclosporine in kidney transplant recipients,
Bokenkamp(1994) concluded that the combined use of both drugs induces larger overgrowths . Nifedipine induced enlargement has been induced experimentally in rats where it appears to be dose dependent.
56
57
Other drugs Vigabatrin is a relatively new medication used in the treatment of epilepsia
Katz et al(1997) reported the first enlargement in an19 year old woman. Cannabis: Gingival enlargement has also been described by case reports in individuals using Cannabis (marijuana) to excess. Gingivitis and alveolar bone loss may also occur in affected areas.
58
Erythromycin Yusok (1989) Association with administration of the antibiotic , erythromycin , in a 6 year old boy being treated for tonsillitis. The overgrowth became evident 1 week after initiation of the drug. Overgrowth involved anterior facial interdental papillae and the palatal and mandibular lingual gingiva.
59
oral hygiene reinforcement Chlorhexidine gluconate rinse SRP Drug substitute Professional recall enlargement persists
Small areas of enlargement No attachment loss Horizontal bone loss Abundance of keratinized tissue
Idiopathic Gingival enlargement Rare condition of undetermined cause. gingivomatosis, elephantiasis, idiopathic fibromatosis, hereditary gingival hyperplasia and congenital familial fibromatosis. Clinical features. Affects the attached gingiva as well as the gingival margin and the interdental papilla The facial and lingual surfaces of the mandible and maxilla are generally affected, Enlarged gingival is pink, firm, and almost leathery in consistency. A characteristic minutely pebbled surface.
61
62
63
Etiology
Hereditary basis The cause is unknown. Studies have found the mode of inheritance to be autosomal recessive in some cases and autosomal dominant in others.
64
Kilpinen etal (1974) found that in some families, gingival enlargement may be linked to retardation of physical development. begins with the eruption of the primary or secondary dentition may regress after extraction, bacterial plaque is a complicating factor. Thomas etal (1994), gingival enlargement has been desribed in tuberous sclerosis, which is an inherited condition characterized by a triad of epilepsy, mental deficiency and cutaneous angiofibromas.
65
Conditioned Enlargements includes hormonal conditions ( eg-pregnancy, puberty), nutritional diseases such as vitamin C deficiency and some cases in which systemic influences is not identified. (Nonspecific conditioned enlargement)
Manifestation of the systemic disease independently of the inflammatory status of the gingival. This group come under systemic diseases causing gingival enlargement
66
Enlargement in Pregnancy
marginal , generalized or single or multiple tumour like masses. increase in the levels of progesterone and estrogen
hormonal changes vascular permeability leading to gingival edema , an increased inflammatory response to dental plaque. changes in subgingival microbiota
67
Marginal enlargement ; 10 % to 70% . presence of bacterial plaque. Clinical features. Varies considerably. Usually generalized and tends to be more prominent interproximally than on the facial and lingual surfaces . Enlarged gingival is bright red, magenta , soft and friable and has a smooth , shiny surface. Bleeding occurs spontaneously or on slight provocation.
68
Tumour like gingival enlargement Also called as the pregnancy tumour. ,epulis granulomatosum, granuloma gravidarum Is an inflammatory response to bacterial plaque modified by the patients condition. Usually appears after 3rd month of pregnancy but may occur earlier. Reported incidence is 1.85-5%
69
Clinical Features
discrete mushroom like, flattened spherical mass that protrudes from the gingival margin or more commonly from the interproximal space Is attached by a sessile or pedunclated base. expand laterally. Pressure from the tongue dusky red or magenta. smooth glistening surface numerous deep red, pinpoint markings. superficial lesion Consistency varies . painless
70
Histopathology
central mass of connective tissue ,. moderately fibrous stroma varying degrees of edema and chronic inflammatory infiltrate. epithelium is thickened , with prominent retepegs and some degree of intracellular and extracellular edema, prominent intercellular bridges, and leukocytic infiltration.
71
72
Clinical Features prominent bulbous interproximal papillae. Often only the facial gingivae are enlarged, and the lingual surfaces are relatively unaltered. Gingival enlargement during puberty has all clinical features associated with chronic inflammatory gingival enlargement. After puberty the enlargement undergoes spontaneous reduction but does not disappear until plaque and calculus are removed.
73
Sutcliffe etal (1972) conducted a longitudinal study of 127 children 11 to 17 years of age showed a high initial prevalence of gingival enlargement that tended to decline with age. Mombelli etal (1990) conducted a longitudinal study of subgingival microbiota of children between the ages of 11 and 14.and their association with clinical parameters has implicated capnocytophaga species in the initiation of pubertal gingivitis.
74
Histopathology Similar to that of chronic inflammation and prominent edema and associated degenerative changes.
75
hemorrhage , collagen degeneration and edema of the gingival connective tissue. response of gingival to plaque scurvy. Clinical features marginal , bluish red, soft, friable, and has a smooth , shiny surface.Hemorrhage , occurring either spontaneously or on slight provocation and surface necrosis with pseudomembrane formation.
76
Histopathology chronic inflammatory cellular infiltration with a superficial acute response. scattered areas of hemorrhage , engorged capillaries. diffuse edema , collagen degeneration and scarcity of collagen fibrils or fibroblasts are striking findings.
77
78
Contd.
79
Etiology : Allergic in origin (like chewingum, dentifrices or various diet component). Clinical features :
Symptoms : Patients may complain of a sore and burning mouth, scaling of lips and angular chelitis.
An associated cheilitis and glossitis has been reported by Kerr (1971) and
Serio (1978 ) HISTOPATHOLOGY : Oral epithelium shows spongiosis and infiltration with inflammatory cells. Ultrastructurally there are signs of damage in the lower spinous layers and the basal layers. Underlying tissue contains a dense infiltrate of plasma cells.
Pyogenic granuloma is a tumourlike gingival enlargement this is considered as exaggerated conditioned response to minor trauma.
Etiology
1. 2. 3. Microorganism : staphylococci, streptococci Trauma Local irritant : it is an inflammatory response to local irritation such as calculus. 4. Hormonal imbalance
Clinical features : Female are affected more than male with common age of occurrence 11-40 yrs. Its size ranges from 0.9- 2 cm. Asymptomatic, may be Papular or nodular Polypoid mass. Lesions are elevated pedunculated or sessile masses with smooth lobulated or even warty. Surface is commonly ulcerated and shows tendency to hemorrhage upon slightest pressure or trauma. Variegated red and white pattern. It may become mature and becomes less vascular and more collagenous
Histopathology mass of granulation tissue with chronic inflammatory cellular infiltration . Endothelial proliferation and the formation of numerous vascular spaces are prominent features.
The surface epithelium is atrophic in some areas and hyper plastic in others. Surface ulceration and exudation are common features. Treatment Removal of lesion, elimination of irritating factors .Bhaskar (1988) reported that the recurrence rate of pyogenic granuloma is 15%.
85
generalized.
it occur due to infiltration of malignant cells into the gingival tissue. The gingiva becomes soft, edematous and swollen. Appearance of gingiva is purplish and glossy.
LEUKEMIC ENLARGEMENT
Histopathology
Edematous and degenerated connective tissue and epithelium Areas of acute necrotizing inflammation with pseudomambranous meshwork of fibrin. Necrotic epithelial cells, polymorphonuclear neutrophils (PMNS) and bacteria are often seen.
88
WEGENERS GRANULOMATOSIS
It is a rare disease characterized by acute granulomatous necrotizing lesions of the respiratory tract, including nasal and oral defects. Renal lesions develop and acute necrotizing vasculitis affects the blood vessels. It involve the orofacial region and include oral mucosal ulceration, gingival enlargement, abnormal tooth mobility, exfoliation of teeth, and delayed healing response.
oral mucosal ulcerations , gingival enlargement , abnormal tooth mobility, exfoliation of teeth and delayed healing response. Granulomatous papillary enlargement is reddish purple and bleeds easily on stimulation. but the condition is considered an immunologically mediated tissue injury.
90
SARCOIDOSIS
It is granulomatous disease of unknown etiology. It starts in individuals in their 20s or 30s. predominantly affects blacks, and can involve almost any organ, including the gingiva, where a red, smooth, painless enlargement may appear. Enlargement is red , smooth and painless
Histopathology
Discrete , non seating whorls of epitheloid cells Multinucleated foreign body type giant cells Peripheral mononuclear cells.
92
Carcinoma-11% Fibroma -9.3% Giant cell tumour -8.4% Papilloma-7.3% Leukoplakia 4.9% Mixed tumour (salivary gland type-2.5%, Angioma-1.5%, Osteofibroma-1.3%, Sarcoma-0.5%, Melanoma-0.5% Myxoma-0.45%, Fibropapilloma-0.4%, Adenoma-0.4%, Lipoma-0.3%
94
FIBROMA
Fibromas of the gingiva arise from the gingival connective tissue or from the periodontal ligament. They are slow growing, spherical tumors that tend to be firm and nodular but may be soft and vascular. Clinical features : Common in 3rd, 4th and 5th decades. Usually painless, but if bitten or injured, there may be pain and discomfort. Sessile dome shaped or slightly pedunculated with smooth contour. There is no alteration in the colour of the gingiva.
Size of enlargement is usually very small but in rare instances may range upto several centimeters in diameter.
soft and myxomatous to firm and elastic consistency. According to the consistency, the tumor is termed as hard fibroma and soft fibroma.
Histopathology Fibromas are composed of bundles of well formed collagen fibers with a scattering of fibrocytes .
PAPILLOMA
Papillomas are benign proliferations of surface epithelium associated with the human papillomavirus (HPV).
Viral subtypes HPV-6 and HPV-11 have been found in most cases of oral papillomas.
CLINICAL FEATURES : Average age of occurrence is in the 3rd and 4th decades of life, only 20 percent cases are found below 20 yrs of age. The lesion appears solitary, wartlike or cauliflower like protuberances. They may be small and discrete or broad, hard elevations with minutely irregular surfaces. Size may vary around 2mm, but it is seldom larger than 2 cms. Tumor with much keratinization is white in color and lesion without much keratinization are grayish pink in color. Consistency is firm when keratinized and soft when non keratinized.
HISTOPATHOLOGY
The papilloma lesion consists of finger like projections of stratified squamous epithelium, often hyperkeratotic with a central core of
GIANT CELL GRANULOMA Types: Peripheral giant cell granuloma it involves gingiva and alveolar mucosa. Central giant cell granuloma occurs as an endosteal lesion in the jaw bones. Peripheral Giant Cell Granuloma Also called as peripheral giant cell reparative granuloma, giant cell
Etiology Injury may be caused by tooth extraction and dental irritation. Chronic Infection Hormonal increased circulating parathormane i.e. primary and secondary hyper parathyroidism.
Predominant in white persons. Ulceration of the margin is occasionally seen. The lesions are painless, vary in size and may cover several teeth. They may be firm or spongy. Color varies from pink to deep red or purplish blue. Microscopic examination is required for definitive diagnosis.
Histopathology
foci of multinuclear giant cells hemosiderin particles in a connective tissue stroma. Areas of chronic inflammation acute involvement at the surface. overlying epithelium -hyperplastic.
Central Giant cell granuloma : These lesions arise within the jaws and produce central cavitation. They occasionally create a deformity of the jaws that makes the gingival appear enlarged.
103
LEUKOPLAKIA Defined by the WHO as a white patch or plaque that does not rub off and cannot be diagnosed as any other disease. Etiology:
Local factors :
Tobacco Alcohol Chronic irritation Candidiasis
Hormones
Drug Anticholinergic Antimetabolic Systemically administered alcohol
LEUKOPLAKIA
CLINICAL FEATURES : Occurs more commonly in older age group i.e. 35-45 yrs and above. Males are affected more frequently than females.
HISTOPATHOLOGY : Leukoplakia exhibits hyperkeratosis and acanthosis, premalignant and malignant cases have a variable degree of atypical epithelial changes that may be mild, moderate, or severe, depending on extent of involvement of the epithelial layers.
Dysplastic changes involve all the layers , it is diagnosed as a carcinoma in situ.
Gingival Cyst
Gingival cysts of microscopic proportions are common Seldom reach a clinically significant size Appear as localized enlargements Involves marginal and attached gingiva. Occur most often on the lingual surface of mandibular canine and premolar areas. Develops from odontogenic epithelium or sulcular epithelium uneventful recovery.
108
Histopathology Lined by thin , flattened epithelium with or without localized area of thickning. Less frequently, following types of epithelium can be found: unkeratinised stratified squamous epithelium, keratinized stratified squamous epithelium and parakeratinised epithelium with palisading basal cells. Other benign tumours also have been desribed as rare or infrequent findings in the gingiva. They include nevis, myoblastoma hemangioma, neurilemoma, neurofibroma, mucus secreting cysts (mucoceles) amd ameloblastoma.
109
MALIGNANT TUMORS OF THE GINGIVA CARCINOMA Clinical features: Common in 5th and 6th decade of life. Carcinoma of mandibular gingiva is more common than maxillary gingiva. More commonly arise in edentulous area. The fixed gingiva is invaded more than the free gingiva. It usually occurs in premolar area.
In maxilla, gingival carcinoma after invades maxillary sinus or it may extend to palate or tonsillar pillars.
It is manifested as an area of ulceration, which may be a purely erosive lesion and may exhibit an exophytic, granular or verrucous type of growth. Quickly spreads from gingiva to alveolar bone.
CARCINOMA
MALIGNANT MELANOMA :
Malignant melanoma is a rare oral tumor that tends to occur in the hard palate
and maxillary gingiva of older persons. It is usually darkly pigmented and is often preceded by localized pigmentation.
Metastasis Metastasis has been reported with various tumors, including adeno carcinoma of the colon, lung carcinoma, primary hepatocellular carcinoma, renal cell carcinoma and testicular tumor.
FALSE ENLARGEMENT False enlargement are not true enlargement of the gingival tissues but may appear as such as a result of increase in size of the underlying osseous or dental tissues. UNDERLYING OSSEOUS LESIONS : Enlargement of the bone subjacent to the gingival area occur most often in tori and exostoses. It can also occur in pagets disease, fibrous dysplasia, cherubism, central giant cell granuloma, ameloblastoma, osteoma and osteosarcoma.
UNDERLYING DENTAL TISSUES During various stages of eruption particularly of the primary dentition, the labial gingiva may show a bulbous marginal distortion caused by superimposition of the bulk of the gingiva on the normal prominence of the enamel in the gingival half of the crown. This enlargement has been termed developmental enlargement. Developmental gingival enlargements are physiologic and usually presents no problems until when it is complicated by marginal inflammation which leads to extensive gingival enlargement.
scaling and rootplaning , surgical removal is the treatment of choice. Gingivectomy flap operation. Tumour like inflammatory enlargements are treated by gingivectomy.
115
Treatment of Periodontal and Gingival Abscesses Acute Periodontal Abscess allevate the pain, control of spread of infection, establish drainage. proper antibiotic regimen started if necessary. Drainage through pocket external incision from the outer surface..
116
117
Alternative medications phenytoin -carbamezipine. valproic acid nifedipine -other calcium channel blockers such as diltiazem or verapamil another class of antihypertensive medications rather than calcium channel blockers,
118
cyclosporine -tacrolimus. There is also preliminary evidence that the antibiotic azithromycin may aid in decreasing the severity of cyclosporine induced gingival enlargement. plaque control as the first step in the treatment of drug induced gingival enlargement. Also , adequate plaque control may aid in preventing or retarding the recurrence of gingival enlargement.in surgically treated cases. surgery , either gingivectomy or the periodontal flap.
119
Treatment of acute symptoms, correction of the gingival enlargement. remove the local irritating factors to control the inflammatory component of the enlargement.. scaling and rootplaning chlorhexidiene mouth washes. Oral hygiene procedures. Progressively deeper scalings. confined to a small area Antibiotics
120
scaling and curettage. surgical excision and scaling and planning of tooth surfaces. the enlargement recurs unless all irritants are removed. Food impaction is frequently an inciting factor
121
Treatment of Gingival Enlargement in Puberty. performing scaling and curettage , removing all sources of irritation and controlling plaque. Surgical removal may be required in severe cases. recurrence due to poor oral hygiene.
122
Conclusion
Gingival enlargement is a common clinical entity and classified in to different types according to the etiological factors and underlying pathological process.It is not always possible to identify the exact etiological factors responsible for such enlargement and classify them in to a particular type .The treatment has to be planned after taking a thorough examination and recording necessary investigations. It includes plaque control, scaling and rootplaning, flap surgery , surgical exision,gingivoplasty and gingivectomy.
123
References:
1)Clinical Periodontology Carranza, Takei, Newman. 10th edition.
2)Thorkild Karring, Jann Lindhe and Pierpaolo Cortellini. Regenerative Periodontal Therapy; Clinical Periodontology; Jan Lindhe 5th edition.. 3)Schafers text book of Oral pathology 5th edition 4)Treatment of drug induced gingival enlargement : aesthetic and functional considerations: Periodontology 2000,Vol 27,2001 ,131-138 5) esentials of medical pharmacology- K D tripathi; 5th edition
6) Ayanoglou CM, Lesty C: Cyclosporin A induced gingival enlargement in rats : A histological , ultra structural and histomorphometric evaluation,. J Periodont Res 1999;34;7-15
124
7) Barak, S, Egelberg IS: Gingival enlargement caused by Nifedipine. Histological findings. J Periodontol 1987;8:639-642 8) Cockey G, Boughman I, Hassel T:Phenytoin induced response of gingival fibroblasts from human twins . J Dent Res 1987:66:320 9)Diagnosis of Periodontal manifestations of systemic diseases. Periodontology 2000 Vol 34, 2004 217-229. 10) Drugs and oral disorders Periodontology 2000 ,Vol18,1998,21-36. 11)Journal of Clinical PeriodontologyVolume 21 Issue 4 Page 256-259, April 1994
125